Deep dive into muscle repair yields new strategies to combat Duchenne muscular dystrophy

$ 8.50

4.9 (762) In stock

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

PDF) Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model

PDF] Duchenne Muscular Dystrophy as a mitochondrial myopathy: Why therapeutically targeting the mitochondria is a plausible treatment avenue

Frontiers Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy

The present and future of regenerative medicine

Frontiers Therapeutic Strategies for Dystrophin Replacement in

Muscular Dystrophy

The present and future of regenerative medicine

De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle - ScienceDirect

Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy

Duchenne Muscular Dystrophy Therapeutics Market Outlook, Size, Prominent Players, Share, Challenges and Forecast 2028

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Todd Dubnicoff The Stem Cellar

Todd Dubnicoff The Stem Cellar